2 курс / Гистология / Митрошина_Е_В_Антигипоксическое_и_нейропротекторное_действие_N_

141

163.Pertwee, R.G., Howlett, A.C., Abood, M.E et al. // International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB. Pharmacol. Rev. 2010. Vol. 62. Р. 588-631.

164.Pimashkin A., Kastalskiy I., Simonov A., Koryagina E., Mukhina I., Kazantsev V. Spiking signatures of spontaneous activity bursts in hippocampal cultures // Frontiers in Computational Neuroscience. 2011. 5(46) doi: 10.3389/fncom.2011.00046.

165.Pine J. Recording action potentials from cultured neurons with extracellular microcircuit electrodes // J. Neurosci. Methods. 1980. Vol. 2, №1. P.19–31.

166.Price T.J., Patwardhan A., Akopian A.N., Hargreaves K.M., Flores C.M. Modulation of trigeminal sensory neuron activity by the dual cannabinoid– vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2- chloroethylamide // Br. J. Pharmacol. 2006. Vol 141, №7. P. 1118-1130.

167.Ralevic V, Kendall D.A., Randall M.D., Smart D. Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function // Life Sci. 2002. Vol 71, №22. Р. 2577– 2594.

168.Riedel G, Davies S.N. Cannabinoid function in learning, memory and plasticity // / In: Cannabinoids. Handbook of Experimental Pharmacology. 2005. Vol. 168. P 445-477

169.Rodriguez J.J., Mackie K., Pickel V.M. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus // Neurosci. 2001. V. 21.P. 823-833.

170.Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor // British Journal of Pharmacology. 2007. Vol. 152, №7. Р. 1092–1101.

171.Sagar D.R., Smith P.A., Millns P.J., Smart D., Kendall D.A., Chapman V. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid

142

N-arachidonoyl-dopamine on primary afferent ibre and spinal cord neuronal responses in the rat // Eur. J. Neurosci. 2004. Vol.20. Р. 175-184.

172.Sagie S, Eliasi Y, Livneh I, Bart Y, Monovich E. Short-and long-term effects of cannabinoids on memory, cognition and mental illness // Harefuah. 2013. vol. 152. Is. 12. P. 737-741.

173.Sánchez-Blázquez P., Rodríguez-Muñoz M., Garzón J. The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia // Front Pharmacol. 2014. Vol.4. Is. 169. doi: 10.3389/fphar.2013.00169.

174.Sapirstein A. and Bonventre J. V. Phospholipases A2 in ischemic and toxic brain injury // Neurochem. Res. 2000. Vol. 25. P. 745-753.

175.Sasamura T, Kuraishi Y. Peripheral and central actions of capsaicin and VR1 receptor // Jpn. J. Pharmacol. 1999. Vol. 80. Is.4. P.275-80.

176.Schäbitz W.R., Giuffrida A., Berger C., Aschoff A., Schwaninger M., Schwab S., Piomelli D. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study // Stroke. 2002. Vol. 33. P. 2112-2114.

177.Schmid P.C., Reddy P.V., Natarajan V., Schmid H.H. Metabolism of N- acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type // J. Biol. Chem. 1983. Vol. 258. P. 9302–9306.

178.Schomacher M., Müller H. D., Sommer C. et al. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia // Brain Research. 2008. Vol. 1240. P. 213–220.

179.Shen, M., Thayer, S.A. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity // Mol. Pharmacol. 1998. Vol. 54. P. 459–462.

180.Shouman B, Fontaine RH, et al. Endocannabinoids potently protect the newborn brain against AMPAkainate receptor-mediated excitotoxic damage // Br. J. Pharmacol. 2006. Vol. 148, №4. Р.442–451.

143

181.Silva A.J., Ciese K.p., Fedorov N.B., Frankland P.W., Kogan J.H. Molecular, cellular, and neuroanatomical substrates of place learning // Neurobiol. Learn. 1998. № 70. Р. 44-61.

182.Sinor A.D., Irvin, S.M., Greenberg, D.A. Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats // Neurosci. Lett. 2000. Vol. 278. P. 157-160.

183.Stelmashook E.V., Lozier E.R., Goryacheva E.S., Mergenthaler P., Novikova S.V., Zorov D.B. and Isaev N.K. Glutamine-mediated protection from neuronal cell death depends on mitochondrial activity // Neurosci. Lett. 2010. Vol.

482(2). Р. 151-155.

184.Sugiura T. Biosynthesis of Anandamide and 2-Arachidonoylglycerol /Cannabinoides and the brain. 2008. Р.15-30.

185.Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain // Biochem Biophys Res Commun. 1995. Vol. 215(1). P. 89-97.

186.Sugiura T., Kobayashi Y., Oka S., Waku K. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance // Prostaglandins Leukot Essent Fatty Acids. 2002. Vol.66. P. 173–

187.Sun Y.X., Tsuboi K., Zhao L.Y. et al. Involvement of N-acylethanolamine- hydrolyzing acid amidase in the degradation of anandamide and other Nacylethanolamines in macrophages // Biochim. Biophys. Acta. 2005. Vol. 1736. P. 211–220.

188.Szabo B. Pharmacology of cannabinoid receptors // Biotrend reviews. 2008.- №2. P. 1-13.

189.Szabo B., Dörner L., Pfreundtner C., Nörenberg W., Starke K. Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum // Neuroscience. 1998. Vol. 85, № 2. P. 395-403.

144

190.Szabo B., Schlicker E. Effects of Cannabinoids on Neurotransmission // In: Cannabinoids. Handbook of Experimental Pharmacology. 2005. Vol. 168. P. 327–

191.Szabo B., Wallmichrath I., Mathonia P., Pfreundtner C. Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulate // Neuroscience. 2000. Vol. 97, №1. P. 89-97.

192.Szallasi A., Cortright D.N., Blum C.A., Eid S.R. The vanilloid receptor TRPV1:10 years from channel cloning to antagonist proof-of-concept // Nat. Rev. Drug Discov. 2007. Vol.6. Р. 357-372.

193.Takahashi N., Sasaki T., Usami A., Matsuki N., Ikegaya Y. Watching neuronal circuit dynamics through functional multineuron calcium imaging (fMCI). // Neuroscience research. 2007. Vol. 58, № 3. P. 219–225.

194.Tan H, Ahmad T, Loureiro M, Zunder J, Laviolette SR. The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophrenia // Front Psychiatry. 2014. Vol. 5. Is. 73. doi: 10.3389/fpsyt.2014.00073

195.Tanaka K. et al. Chronic cerebral hypoperfusion disrupts discriminative behavior in acquired-learning rats // J. Neurosci. Methods. 1998. Vol. 84, № 1-2. P. 63-68.

196.Ternianov A., Pérez-Ortiz J.M., Solesio M.E., García-Gutiérrez M.S., Ortega-Álvaro A., Navarrete F., Leiva C., Galindo M.F., Manzanares J. Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine // Neurobiol Aging. 2012. Vol. 33, № 2. P.421-425.

197.Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., Sniezek, J.E., // Traumatic brain injury in the United States: a public health perspective. J. Head Trauma Rehabil. 1999. Vol.14. Р. 602-615.

198.Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons // J. Neurophysiol. 1997. Vol. 78. Is.1. P.43-50.

145

199.Van Der Stelt M., Di Marzo V. Endovanilloids. Putative endogenous ligands of transient receptor potential vanilloid 1 channels // Eur J Biochem. 2004. Vol. 27. P.1827-1834.

200.Van der Stelt M., van Kuik J.A., Bari M. et al. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase // J. Med. Chem. 2002. Vol. 45. P. 3709–3720.

201.Van der Stelt M., Veldhuis W.B. et al. Neuroprotection by Delta9tetrahydrocannabinol, the main active compound in marijuana, against ouabaininduced in vivo excitotoxicity // J. Neurosci. 2001. Vol 21, №17. Р. 6475–6479.

202.Virley D. et al. Primary CA1 and conditionally immortal MHP36 cell grafts restore conditional discrimination learning and recall in marmosets after excitotoxic lesions of the hippocampal CA1 field // Brain. 1999. Vol. 122, №. 12. P. 2321-2335.

203.Wagenaar D.A., Pine J., Potter S. M. An extremely rich repertoire of bursting patterns during the development of cortical cultures // BMC Neurosci. 2006. Feb 7. Art. no. 11.

204.Walker J.M., Krey J.F., Chen J.S., Vefring E., Jahnsen J.A., Bradshaw H., Huang S.M. Targeted lipidomics: fatty acid amides and pain modulation // Prostaglandins Other Lipid Mediat. 2005. Vol. 77. Is. 1-4. P.35-45.

205.Wang K. K. Calpain and caspase: can you tell the difference? // Trends. Neurosci. 2000. Vol. 23. P. 20-26.

206.Westlake T.M., Howlett A.C., Bonner T.I., Matsuda L.A., Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains // Neuroscience. 1994. Vol. 63. P. 637–652.

207.Won S.J., Kim D.Y., Gwag B.J. Cellular and molecular pathways of ischemic neuronal death // J Biochem Mol Biol. 2002. Vol. 35. Is. 1. P. 67-86.

208.Won H., Lee H.R., Gee H.Y., Mah W., Kim J.I., Lee J., Ha S., Chung C., Jung E.S., Cho Y.S., Park S.G., Lee J.S., Lee K., Kim D., Bae Y.C., Kaang B.K.,

146

Lee M.G., Kim E. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function // Nature. 2012. Vol. 486. Is. 7402. P. 261265.

209.Xiang G., Pan L., Huang L., Yu Z., Cheng J., Xing W., ZhouY. Microelectrode array-based system for neuropharmacological applications with cortical neurons cultured in vitro // Biosens Bioelectron. 2007. V. 22(11). P. 2478– 2484.

210.Xiong Y., Mahmood A., Chopp M. Emerging treatments for traumatic brain injury // Expert Opin Emerg Drugs. 2009. Vol.14, №1ю Р.67-84.

211.Yamamoto M., Takahashi K., Ohyama M., Yamaguchi T., Saitoh S., Yatsugi S., Kogure K. Behavioral and histological changes after repeated brief cerebral ischemia by carotid artery occlusion in gerbils // Brain Res. 1993. Vol. 608, № 1. P. 16-20.

212.Younts TJ, Castillo PE. Endogenous cannabinoid signaling at inhibitory interneurons // Curr Opin Neurobiol. 2014. Vol. 26. P. 42-50.

213.Zakharov Y.N., Mitroshina E.V., Shirokova O.М., Mukhina I.V. Calcium transient imaging as tool for neuronal and glial network interaction study // Springer Proceedings in Mathematics and Statistics (Models, Algorithms, and Technologies for Network Analysis). 2013. Р. 225-232.

214.Zhang M, Martin BR, Adler MW, Razdan RK, Jallo JI, Tuma RF. Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model //J. Cereb. Blood. Flow. Metab. 2007. Vol.27. Р.1387–1396.

215.Zhang M., Martin B.R. et al. Modulation of The Balance Between Cannabinoid CB1 and CB2 Receptor Activation During Cerebral Ischemic/Reperfusion Injury // Neuroscience. 2008. Vol. 152, №3. 753–760.

216.Zhang M., Martin B.R. et al., Modulation of cannabinoid receptor activation as a neuroprotective strategy for EAE and stroke // J. Neuroimmune Pharmacol. 2009. Vol. 4, 32. Р. 249-259.

147

217. Zimmer A. et al. Increased mortality, hypoactivity and hypoalgesia in cannabinoid CB1 receptor knockout mice // Proc. Natl. Acad. Sci. 1996. Vol. 7. P. 5780-5785.